Cardiovascular outcomes played a critical role in this research
Medically Supervised for Safety & Efficacy: Ensures appropriate dosing and administration by trained professionals
Another adverse impact of this shortage, she said, is that patients have lower compliance levels with a daily injectable medication, compared to a weekly one.
Great to see self-amplifying mRNA being pushed into non-vaccine applications with such a strong proof of concept
Semaglutide showed a lower risk of the secondary composite endpoint of heart failure hospitalization or urgent heart failure visit compared to sitagliptin in the expanded populations (HR 0.61, 95% CI 0.57 to 0.66)
Jimmy Johannes, MD, an internist, pulmonologist, and critical care medicine specialist at MemorialCare Long Beach Medical Center in Long Beach, CA, said the results were interesting but cautioned that more research is needed